Electromed (ELMD) Liabilities and Shareholders Equity (2011 - 2026)

Electromed's (ELMD) quarterly Liabilities and Shareholders Equity came in at $59.5 million in Q1 2026, up 13.39% year-on-year from $52.5 million in Q1 2025, and up 8.31% on a QoQ basis from $54.9 million in Q4 2025.

Electromed (ELMD) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

Electromed (ELMD) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $59.5 million in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 13.39% year-over-year to $59.5 million in Q1 2026; TTM through Mar 2026 was $221.8 million, a 7.74% increase from a year earlier, with the FY2025 full-year figure at $53.8 million, up 3.0% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $59.5 million, up from $54.9 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for ELMD reached as high as $59.5 million in Q1 2026 and fell as low as $39.0 million in Q1 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $48.1 million across 5 years, with a median of $48.9 million in 2024.
  • Across the five-year window, Liabilities and Shareholders Equity grew 14.15% in 2024 and increased 3.0% in 2025, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $41.4 million in 2022, then grew by 13.46% to $47.0 million in 2023, then climbed by 11.31% to $52.3 million in 2024, then rose by 5.04% to $54.9 million in 2025, then increased by 8.31% to $59.5 million in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $59.5 million in Q1 2026, $54.9 million in Q4 2025, and $53.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Electromed 313.26 Mn 296.27 Mn 14.64 Mn 59.47 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 59.47 Mn
Dec 31, 2025 54.91 Mn
Sep 30, 2025 53.61 Mn
Jun 30, 2025 53.80 Mn
Mar 31, 2025 52.45 Mn
Dec 31, 2024 52.27 Mn
Sep 30, 2024 48.92 Mn
Jun 30, 2024 52.23 Mn
Mar 31, 2024 48.90 Mn
Dec 31, 2023 46.96 Mn
Sep 30, 2023 44.07 Mn
Jun 30, 2023 45.81 Mn
Mar 31, 2023 42.84 Mn
Dec 31, 2022 41.39 Mn
Sep 30, 2022 40.13 Mn
Jun 30, 2022 41.36 Mn
Mar 31, 2022 39.02 Mn
Dec 31, 2021 38.20 Mn
Sep 30, 2021 37.90 Mn
Jun 30, 2021 37.11 Mn